Suplatast tosilate
Alternative Names: IPD; IPD 1151T; Suplatast tosylate; YM 672Latest Information Update: 05 Nov 2023
Price :
$50 *
At a glance
- Originator Taiho Pharmaceutical
- Developer Astellas Pharma; Senju Pharmaceutical; Taiho Pharmaceutical
- Class Antiallergics; Antiasthmatics; Antihistamines; Antitussives; Arylsulfonates; Small molecules
- Mechanism of Action Cytokine inhibitors; Histamine release inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Allergic rhinitis; Asthma; Atopic dermatitis
- No development reported Prostatitis; Pulmonary eosinophilia
- Discontinued Interstitial cystitis
Most Recent Events
- 06 Nov 2007 Discontinued - Phase-II for Interstitial cystitis in Denmark (PO) in November 2007 (Astellas pipeline circulated by AB - disc)
- 06 Nov 2007 Discontinued - Phase-II for Interstitial cystitis in Germany (PO) in November 2007 (Astellas pipeline circulated by AB - disc)
- 06 Nov 2007 Discontinued - Phase-II for Interstitial cystitis in Sweden (PO) in November 2007 (Astellas pipeline circulated by AB - disc)